VANCOUVER, BC, Dec. 18, 2020 /CNW/ - H-Source Holdings Ltd.
(TSXV: HSI) (OTCQB: HSCHF) (the "Company" or
"H-Source") is pleased to announce the resumption of trading
as per the directions of the British Columbia Securities Exchange.
H-Source has met the requirements to enable the full reinstatement
of the Canadian markets.
H-Source would also like to provide an update on the previously
announced Press Release dated May 12,
2020
(https://www.newswire.ca/news-releases/h-source-announces-hsource1-in-europe-for-medical-supplies-and-covid-19-844135810.html).
H-Source has successfully pivoted to pursuing various Personal
Protection Equipment ("PPE") leveraging its healthcare
knowledge and technology platform which provides inventory
management with central warehouse tracking for
hospitals, governments, and businesses to procure highly needed
medical supplies including PPE, medical surgical supplies,
pharmaceuticals and capital equipment.
John Kupice (CEO of H-Source)
stated: "The current global pandemic is putting tremendous pressure
on the demand for PPE supplies, as well as supply chains and
logistics. Leveraging the H-Source platform and healthcare
knowledge enables our trusted partners to achieve secure levels of
procurement and fulfillment. This has allowed us to build strong
pipeline of PPE projects."
Mr. Kupice further comments: "H-Source will continue to update
all of our valued shareholders and business partners as we continue
to rollout and execute on various strategies and opportunities, and
we wish to sincerely thank you for your patience and confidence
during this tumultuous time".
About H-Source Holdings
Ltd.
H-Source Holdings Ltd. is a proprietary, patented
technology company operating within the healthcare industry through
its wholly-owned subsidiary, H-Source, Inc. The Company has
developed an advanced technology solutions stack that provides
participating members a private, secure, Software As A Service
("SAAS") platform to engage in the buy, sell, track, and
transfer of medical supplies, pharmaceuticals, capital equipment,
and medical devices. Integrating advanced Artificial Intelligence
("AI") and Business Intelligence ("BI") enhance the data analytics
for supply chain optimization. The platform is FDA and DSCSA
compliant for pharmaceuticals and GS-1 UDI/GTIN for devices
including serialization, ownership, and custody in extended
modules. Blockchain is offered as an add-on, at an additional cost,
for robust security and traceability. Additionally, the H-Source
platform provides all the accounting and data allowing buyers and
sellers to capture product transactions and custody
movements. This platform is designed to increase and maximize
supply chain efficiency while reducing costs by moving products
directly from manufacturers, providers, and distributors to
businesses or consumers. For more information,
please visit http://h-source.com/.
On behalf of the board of directors of H-Source Holdings
Ltd.
John Kupice
CEO & Director
CAUTIONARY DISCLAIMER STATEMENT: The TSXV has not
reviewed and does not accept responsibility for the adequacy or
accuracy of the content of this news release.
This news release contains forward-looking statements
relating to the completion of the listing of the Company's shares
on the TSXV and other statements that are not historical facts.
Forward-looking statements are often identified by terms such as
"will", "may", "should", "anticipate", "expects" and similar
expressions. All statements other than statements of historical
fact, included in this release are forward-looking statements that
involve risks and uncertainties. There can be no assurance that
such statements will prove to be accurate and actual results and
future events could differ materially from those anticipated in
such statements. Important factors that could cause actual results
to differ materially from the Company's expectations include the
failure to satisfy the conditions of the TSXV and other risks
detailed from time to time in the filings made by the Company with
securities regulations.
The reader is cautioned that assumptions used in the
preparation of any forward-looking information may prove to be
incorrect. Events or circumstances may cause actual results to
differ materially from those predicted, as a result of numerous
known and unknown risks, uncertainties, and other factors, many of
which are beyond the control of the Company. The reader is
cautioned not to place undue reliance on any forward-looking
information. Such information, although considered reasonable by
management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are
expressly qualified by this cautionary statement. The
forward-looking statements contained in this news release are made
as of the date of this news release and the Company will update or
revise publicly any of the included forward-looking statements as
expressly required by applicable law.
SOURCE H-Source Holdings Ltd.
